1 / 12

The authors have no financial interest to disclose Topical IL-1ra provided by TheraKine , Inc.

ASCRS 2010, Boston, MA. Topical Interleukin-1 receptor antagonist therapy and corneal healing after photorefractive keratectomy in New Zealand White rabbits Brett Davies, Capt, USAF, MC; Vasudha Panday, Maj, USAF, MC; Charles Reilly, Lt Col, USAF, MC ; Matthew Caldwell, Maj, USAF, MC

zagiri
Download Presentation

The authors have no financial interest to disclose Topical IL-1ra provided by TheraKine , Inc.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ASCRS 2010, Boston, MA Topical Interleukin-1 receptor antagonist therapy and corneal healing after photorefractive keratectomy in New Zealand White rabbits Brett Davies, Capt, USAF, MC; Vasudha Panday, Maj, USAF, MC; Charles Reilly, Lt Col, USAF, MC ; Matthew Caldwell, Maj, USAF, MC Wilford Hall Air Force Medical Center San Antonio, TX The authors have no financial interest to disclose Topical IL-1ra provided by TheraKine, Inc. The conclusions do not necessarily reflect the views of the USAF or the DOD

  2. Purpose Vs • This is a randomized, blinded study designed to compare topical Interleukin-1 antagonist (IL-1ra) against standard steroid treatment following photorefractive keratectomy (PRK).

  3. Steroids Glaucoma Cataracts Secondary infection Delayed wound healing

  4. Interleukin-1

  5. Methods

  6. Outcome Measures • Time to re-epithelization • Weekly slit lamp exam for haze • Pentacam evaluation prior to and at weeks 1,2,3, and 7 • Histologic exam at week 7

  7. Results Time to re-epithelization: No difference in epithelial healing time

  8. Results- Slit lamp exam p<0.005 p<0.005 p=0.392 p=0.536 Subjective Haze

  9. Results- Pentacam Haze p<0.0001

  10. Results-Histology Steroids 2.5mg 1.25mg 0.25mg Central Foam Layer p = 0.725 Thickest Foam Layer p = 0.997

  11. Conclusions • IL-1ra does not increase epithelial healing time • No difference in foam layer between treatment groups • Steroids significantly better than other groups on subjective haze analysis at weeks 4 and 5 • IL1-ra reduced objective haze (Pentacam) similar to steroids at 1 month post op • Lower doses of IL1-ra reduced objective haze more than higher dose Further studies needed to determine side effects of IL-1ra as well as response in human cornea

  12. References • Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993; 328: 106 • Le J, Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest 1987; 56: 234. • Kijlstra A. The role of cytokines in ocular inflammation. Br J Ophthalmol 1994; 78: 885 • Girard MT, Matsubara M, Fini ME. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci 1991; 32: 2441. • Yamada, J, Dana MR, Sotozono C, Kinoshita S. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Experimental Eye Research2003; 76(2): 161-7. • Biswas PS, Banerjee K, Zheng M, Rouse BT. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. J Leukoc Biol. 2004; 76(4): 868-75 • Netto MV. Wilson SE. Corneal wound healing relevance to wavefront guided laser treatments. [Review] [58 refs] Ophthalmology Clinics of North America 2004; 17(2): 225-31 • Kaji Y. Yamashita H. Oshika T. Corneal wound healing after excimer laser keratectomy. [Review] [28 refs] Seminars in Ophthalmology 2003; 18(1): 11-6 • Alio JL. Perez-Santonja JJ. Tervo T. Tabbara KF. Vesaluoma M. Smith RJ. Maddox B. Maloney RK. Postoperative inflammation, microbial complications, and wound healing following laser in situ keratomileusis. [Review] [82 refs] Journal of Refractive Surgery 2000; 16(5): 523-38 • Wachtlin J. Langenbeck K. Schrunder S. Zhang EP. Hoffmann F. Immunohistology of corneal wound healing after photorefractive keratectomy and laser in situ keratomileusis. Journal of Refractive Surgery 1999; 15(4): 451-8 • Kato T. Nakayasu K. Hosoda Y. Watanabe Y. Kanai A. Corneal wound healing following laser in situ keratomileusis (LASIK): a histopathological study in rabbits. British Journal of Ophthalmology 1999; 83(11): 1302-5 • Gan, L., Hamberg-Nystrom, H, Fagerholm, P, Van Setten, G.Cellular proliferation and leukocyte infiltration in the rabbit cornea after photorefractive keratectomy.ActaOphthalmologicaScandinavica. 79(5):488-492, October 2001

More Related